Novo Nordisk A S
Held by 14 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 670100205 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 14 of the investors we track own this stock. In the latest quarter, 6 of them bought more of it and 8 sold some or all of theirs (2 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
14
0 vs last quarter (like-for-like)
Total value held
$2.20B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
0.3%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$418.53M
+23.5% vs last quarter
Net shares bought
-2.6M
Est. net flow -$123.85M
Quarter activity
6 bought · 8 sold
2 new · 2 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns NVO?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns NVO? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox | Dodge & Cox | 20.40M | $977.84M | 0.5% | Added | +1.1M | +5.5% | +$50.98M |
| 2 | Ken Fisher | Fisher Asset Management | 8.32M | $399.10M | 0.1% | Reduced | -696.2K | -7.7% | -$33.37M |
| 3 | Fred Alger | Fred Alger Management | 4.91M | $235.27M | 0.8% | New | +4.9M | — | +$235.27M |
| 4 | Jim Simons | Renaissance Technologies | 3.03M | $145.37M | 0.2% | Reduced | -364.7K | -10.7% | -$17.48M |
| 5 | Tom Gayner | Markel Group | 2.87M | $137.58M | 1.0% | Held | 0 | 0.0% | $0 |
| 6 | Israel Englander | Millennium Management | 2.04M | $97.60M | 0.1% | Added | +627.1K | +44.5% | +$30.06M |
| 7 | Causeway | Causeway Capital Management | 1.68M | $80.42M | 0.9% | Added | +503.4K | +42.9% | +$24.13M |
| 8 | Ken Griffin | Citadel Advisors | 1.37M | $65.50M | 0.0% | Reduced | -1.4M | -50.1% | -$65.69M |
| 9 | David Shaw | D.E. Shaw & Co. | 697.57K | $33.44M | 0.0% | Reduced | -1.3M | -65.8% | -$64.31M |
| 10 | Boston Partners | Boston Partners Global Investors | 507.49K | $24.34M | 0.0% | Added | +362.5K | +249.9% | +$17.38M |
| 11 | Beutel Goodman | Beutel, Goodman & Co | 55.41K | $2.66M | 0.0% | Reduced | -2.3K | -4.0% | -$110.24K |
| 12 | Steve Cohen | Point72 Asset Management | 29.20K | $1.40M | 0.0% | New | +29.2K | — | +$1.40M |
| 13 | Two Sigma | Two Sigma Investments | 15.80K | $757.45K | 0.0% | Reduced | -6.3M | -99.7% | -$300.62M |
| 14 | Baillie Gifford | Baillie Gifford & Co | 82 | $3.93K | 0.0% | Held | 0 | 0.0% | $0 |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Jeremy Grantham | GMO | -28.0K | $1.03M |
| Francois Rochon | Giverny Capital | -12.4K | $455.70K |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kevin Hern Politician | Aug 31, 2026 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Kevin Hern Traditional IRA | Sep 25, 2026 | 25 days | PTR ↗ |
| Kevin Hern Politician | Sep 10, 2026 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Kevin Hern Traditional IRA | Sep 25, 2026 | 15 days | PTR ↗ |
| Scott Franklin Politician | Aug 26, 2026 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fidelity Roth IRA | Sep 17, 2026 | 22 days | PTR ↗ |
| Ro Khanna Politician | Mar 13, 2026 | NVO | NOVO-NORDISK A/S ADR ADR CMN x scanned | Sale | $50,001 - $100,000 | Est. $75,000 (midpoint of reported range $50,001–$100,000) | Spouse | — | Apr 7, 2026 | 25 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 30, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 22 days | PTR ↗ |
| Lisa McClain Politician | Oct 31, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab 401K > Schwab 893 | Nov 21, 2025 | 21 days | PTR ↗ |
| Lisa McClain Politician | Sep 11, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Oct 22, 2025 | 41 days | PTR ↗ |
| Val T. Hoyle Politician | Oct 29, 2024 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Rollover IRA | Sep 12, 2025 | 318 days Late | PTR ↗ |
| Lisa McClain Politician | Aug 4, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Sep 12, 2025 | 39 days | PTR ↗ |
| Scott Franklin Politician | Aug 4, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | Fidelity Traditional IRA | Aug 14, 2025 | 10 days | PTR ↗ |
| Scott Franklin Politician | Aug 4, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fidelity Roth IRA | Aug 14, 2025 | 10 days | PTR ↗ |
| Scott Franklin Politician | Aug 4, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fidelity Traditional IRA | Aug 14, 2025 | 10 days | PTR ↗ |
| Scott Franklin Politician | Aug 4, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Fidelity Roth IRA | Aug 14, 2025 | 10 days | PTR ↗ |
| Lisa McClain Politician | Jun 9, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 65 days Late | PTR ↗ |
| Lisa McClain Politician | Jul 10, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Charles Schwab Brokerage Account 924 | Aug 13, 2025 | 34 days | PTR ↗ |
| Laurel M. Lee Politician | May 8, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Jun 22, 2025 | 45 days | PTR ↗ |
| Byron Donalds Politician | Mar 20, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Moran Wealth IRA | Apr 14, 2025 | 25 days | PTR ↗ |
| Byron Donalds Politician | Mar 20, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Apr 14, 2025 | 25 days | PTR ↗ |
| Scott Franklin Politician | Mar 27, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Fidelity Roth IRA | Apr 11, 2025 | 15 days | PTR ↗ |
| Scott Franklin Politician | Mar 27, 2025 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Self | Fidelity Traditional IRA | Apr 11, 2025 | 15 days | PTR ↗ |
| Byron Donalds Politician | Oct 7, 2022 | NVO | Novo-Nordisk As Adr (NVO) scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Nov 8, 2024 | 763 days Late | PTR ↗ |
| Byron Donalds Politician | Oct 7, 2022 | NVO | Novo-Nordisk As Adr (NVO) scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Nov 8, 2024 | 763 days Late | PTR ↗ |
| John James Politician | Sep 4, 2024 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 6, 2024 | 2 days | PTR ↗ |
| John James Politician | Nov 10, 2023 | NVO | Novo Nordisk A/S Common Stock (NVO) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | John A. James Children’s Trust | Sep 2, 2024 | 297 days Late | PTR ↗ |